No Prescription |
 |
 | ||
|
S Citadep Lexapro |
|
| ||
No Prescription » Prescription Drugs 14 » S Citadep Lexapro Escitalopram is prescribed for major depression--a persistently low mood that interferes with daily functioning. To be considered major depression must occur nearly every day for at least two weeks and must include at least five of the following symptoms: low mood loss of interest in usual activities significant change in weight or appetite change in sleep patterns agitation or lethargy fatigue feelings of guilt or worthlessness slowed thinking or lack of concentration and thoughts of suicide.Escitalopram is also prescribed for generalized anxiety disorder a condition marked by excessive worry and anxiety that is hard to control and interferes with daily life. To be diagnosed with this disorder your symptoms must have lasted at least 6 months and you must have at least three of the following: restlessness fatigue poor concentration irritability muscle tension and sleep disturbances.Escitalopram works by boosting levels of serotonin one of the chief chemical messengers in the brain. The drug is a close chemical cousin of the antidepressant medication Celexa. Other antidepressants that work by raising serotonin levels include Paxil Prozac and Zoloft. Buy S Citadep Lexapro and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About S Citadep Lexapro: Product Type: Prescription Drugs 14 S-Citadep ( Lexapro Feliz -S Generic Escitalopram ) S-Citadep (Lexapro Feliz -S Generic Escitalopram) Lexapro Feliz -S Generic Escitalopram 10mg tabs Lexapro Feliz -S Generic Escitalopram S-Citadep
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
